机译:PD-L1(克隆SP142)对甲氨蝶呤相关的淋巴抑制性疾病的免疫组化评估,其强调肿瘤PD-L1(克隆SP142) - 阳性经典霍奇金淋巴瘤型
Nagoya Univ Hosp Dept Pathol &
Lab Med Nagoya Aichi Japan;
Nagoya Univ Hosp Dept Pathol &
Lab Med Nagoya Aichi Japan;
Mansoura Univ Dept Pathol Fac Med Mansoura Egypt;
Nagoya Univ Hosp Dept Pathol &
Lab Med Nagoya Aichi Japan;
Aichi Med Univ Hosp Dept Surg Pathol Nagakute Aichi Japan;
Aichi Med Univ Hosp Dept Surg Pathol Nagakute Aichi Japan;
Aichi Canc Ctr Hosp Dept Pathol &
Mol Diagnost Nagoya Aichi Japan;
Nagoya Univ Hosp Dept Pathol &
Lab Med Nagoya Aichi Japan;
Nagano Prefectural Shinshu Med Ctr Dept Clin Lab Nagano Japan;
Methotrexate-associated lymphoproliferative disorder; lassic Hodgkin lymphoma; eoplastic PD-L1 expression; lone SP142;
机译:PD-L1(克隆SP142)对甲氨蝶呤相关的淋巴抑制性疾病的免疫组化评估,其强调肿瘤PD-L1(克隆SP142) - 阳性经典霍奇金淋巴瘤型
机译:编程细胞死亡配体1(克隆SP142)在纵隔复合淋巴瘤中的诊断用途:两种情况的报告
机译:PUB026 PD-L1表达,使用SP142和22C3抗体克隆,在NSCLC患者中具有已知EGFR和ALK基因的状态
机译:PD-L1的表达及其在胃癌中的预后意义:三个PD-L1抗体克隆(SP142、28-8和E1L3N)的回顾性比较
机译:PD-L1表达及胃癌中的预后意义:三种Pd-L1抗体克隆的回顾性比较(SP142,28-8和E1L3N)